HAMZA, S. Et Al. 2022. Tamoxifen reduces hepatocyte growth factor secretion in breast cancer cells with high NLRP3 expression. 56th Annual Scientific Meeting of the European Society for Clinical Investigation-ESCI 2022 , (Bari, Italy).

HAMZA, S., GARANINA, E., ALSAADI, M., TEZCAN, G., RIZVANOV, A., & KHAIBOULLINA, S., (2022). Tamoxifen reduces hepatocyte growth factor secretion in breast cancer cells with high NLRP3 expression . 56th Annual Scientific Meeting of the European Society for Clinical Investigation-ESCI 2022, Bari, Italy

HAMZA, SHAIMAA Et Al. "Tamoxifen reduces hepatocyte growth factor secretion in breast cancer cells with high NLRP3 expression," 56th Annual Scientific Meeting of the European Society for Clinical Investigation-ESCI 2022, Bari, Italy, 2022

HAMZA, SHAIMAA Et Al. "Tamoxifen reduces hepatocyte growth factor secretion in breast cancer cells with high NLRP3 expression." 56th Annual Scientific Meeting of the European Society for Clinical Investigation-ESCI 2022 , Bari, Italy, 2022

HAMZA, S. Et Al. (2022) . "Tamoxifen reduces hepatocyte growth factor secretion in breast cancer cells with high NLRP3 expression." 56th Annual Scientific Meeting of the European Society for Clinical Investigation-ESCI 2022 , Bari, Italy.

@conferencepaper{conferencepaper, author={SHAIMAA HAMZA Et Al. }, title={Tamoxifen reduces hepatocyte growth factor secretion in breast cancer cells with high NLRP3 expression}, congress name={56th Annual Scientific Meeting of the European Society for Clinical Investigation-ESCI 2022}, city={Bari}, country={Italy}, year={2022}}